Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lawrence Charles Paoletti, Ph.D.

Co-Author

This page shows the publications co-authored by Lawrence Paoletti and Michael Wessels.
Connection Strength

0.644
  1. Regulation and function of pilus island 1 in group B streptococcus. J Bacteriol. 2012 May; 194(10):2479-90.
    View in: PubMed
    Score: 0.130
  2. Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates. J Clin Invest. 1992 Jan; 89(1):203-9.
    View in: PubMed
    Score: 0.129
  3. An oligosaccharide-tetanus toxoid conjugate vaccine against type III group B Streptococcus. J Biol Chem. 1990 Oct 25; 265(30):18278-83.
    View in: PubMed
    Score: 0.118
  4. Structural properties of group B streptococcal type III polysaccharide conjugate vaccines that influence immunogenicity and efficacy. Infect Immun. 1998 May; 66(5):2186-92.
    View in: PubMed
    Score: 0.050
  5. Immunogenicity and protective activity in animals of a type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Infect Dis. 1995 Apr; 171(4):879-84.
    View in: PubMed
    Score: 0.040
  6. Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine. Infect Immun. 1994 Aug; 62(8):3236-43.
    View in: PubMed
    Score: 0.038
  7. Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine. Infect Immun. 1993 Nov; 61(11):4760-6.
    View in: PubMed
    Score: 0.037
  8. Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine. Infect Immun. 1992 Oct; 60(10):4009-14.
    View in: PubMed
    Score: 0.034
  9. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus. J Clin Invest. 1990 Nov; 86(5):1428-33.
    View in: PubMed
    Score: 0.030
  10. Measurement of human antibodies to type III group B Streptococcus. Infect Immun. 1999 Aug; 67(8):4303-5.
    View in: PubMed
    Score: 0.014
  11. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J Infect Dis. 1999 Jan; 179(1):142-50.
    View in: PubMed
    Score: 0.013
  12. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest. 1996 Nov 15; 98(10):2308-14.
    View in: PubMed
    Score: 0.011
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.